FDA rejects Atara Biotherapeutics' EBVALLO drug application

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. WMT
5. ADI
6. ROST
7. BILL
8. MRK
9. MRNA
10. NTES

Go back to FDA rejects Atara Biotherapeutics' EBVALLO drug application
(NASDAQ: ATRA) Delayed: 9.38 -0.22 (2.29%)
Previous Close $9.60    52 Week High $40.80 
Open $9.60    52 Week Low $12.45 
Day High $9.74    P/E N/A 
Day Low $9.14    EPS $0.00 
Volume 28,020